Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (341-350 of 525) with videos related to

Pageof 53
Sort By:
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Preclinical Evaluation of <sup>213</sup>Bi- and <sup>225</sup>Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate CancerSangeeta Ray Banerjee, Ala Lisok, Il Minn, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Magnetic Resonance in Medicine|December 25, 2019
d-glucose weighted chemical exchange saturation transfer (glucoCEST)-based dynamic glucose enhanced (DGE) MRI at 3T: early experience in healthy volunteers and brain tumor patientsXiang Xu, Akansha Ashvani Sehgal, Nirbhay N Yadav, et al.
Diagnostic and Interventional Imaging|August 2, 2025
Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor typesJorge D Oldan, Anurag Anugu, Md Zobaer Islam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2019
<sup>177</sup>Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapySangeeta Ray Banerjee, Vivek Kumar, Ala Lisok, et al.
EJNMMI Research|August 26, 2024
A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissuesCatherine A Foss, Ravi Naik, Deepankar Das, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2015
Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumorsYumin Oh, Magdalena Swierczewska, Tae Hyung Kim, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for BrainLucia Tamborini, Ying Chen, Catherine A Foss, et al.
EJNMMI Radiopharmacy and Chemistry|January 11, 2026
Fluorine-18-labeled PET radiotracers for imaging the macrophage colony-stimulating factor 1 receptor (CSF1R)Deepankar Das, Hyojin Cha, Ravi Naik, et al.
Pageof 53

Showing results (341-350 of 525) with videos related to

Sort By:
Pageof 53
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Preclinical Evaluation of <sup>213</sup>Bi- and <sup>225</sup>Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate CancerSangeeta Ray Banerjee, Ala Lisok, Il Minn, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Magnetic Resonance in Medicine|December 25, 2019
d-glucose weighted chemical exchange saturation transfer (glucoCEST)-based dynamic glucose enhanced (DGE) MRI at 3T: early experience in healthy volunteers and brain tumor patientsXiang Xu, Akansha Ashvani Sehgal, Nirbhay N Yadav, et al.
Diagnostic and Interventional Imaging|August 2, 2025
Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor typesJorge D Oldan, Anurag Anugu, Md Zobaer Islam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2019
<sup>177</sup>Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapySangeeta Ray Banerjee, Vivek Kumar, Ala Lisok, et al.
EJNMMI Research|August 26, 2024
A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissuesCatherine A Foss, Ravi Naik, Deepankar Das, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2015
Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumorsYumin Oh, Magdalena Swierczewska, Tae Hyung Kim, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for BrainLucia Tamborini, Ying Chen, Catherine A Foss, et al.
EJNMMI Radiopharmacy and Chemistry|January 11, 2026
Fluorine-18-labeled PET radiotracers for imaging the macrophage colony-stimulating factor 1 receptor (CSF1R)Deepankar Das, Hyojin Cha, Ravi Naik, et al.
Pageof 53